close Icon

Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.

Eddy KE, Vogel JP, Zahroh RI, Bohren MA

  • Journal BJOG : an international journal of obstetrics and gynaecology

  • Published 04 Oct 2021

  • Volume 129

  • ISSUE 3

  • Pagination 379-391

  • DOI 10.1111/1471-0528.16913


remains underused, particularly in low- and middle-income countries (LMICs).

to prevent or treat pre-eclampsia/eclampsia.

We searched MEDLINE, EMBASE, Emcare, CINAHL, Global Health and Global Index Medicus, and grey literature for studies published between January 1995 and June 2021.

in healthcare settings, from the perspectives of healthcare providers, administrators and policy-makers, were eligible for inclusion.


availability at point of use (availability, resourcing and pathways to care) and knowledge translation (dissemination of research and recommendations). Within each COM-B domain, we mapped facilitators and barriers to physical and psychological capability, physical and social opportunity, and how the interplay between these domains influences motivation.

in clinical care. Such action is needed to ensure this life-saving treatment is widely available and appropriately used.

for pre-eclampsia and eclampsia.